Longeveron Profit Margin

Longeveron (LGVN) currently reports a profit margin of -1977.59% as of June 2026. That compares with -901.5% in the prior-year period — down 119.4% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Longeveron's profit margin history and peer comparisons.

Longeveron's profit margin decreased from -901.5% to -1977.59% — a 119.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Longeveron's profit margin of -1977.59% is lower than the Healthcare sector average of 13.76%. That is roughly 14471.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Longeveron's current -1977.59% should be judged against Healthcare norms (sector average: 13.76%) and against LGVN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1977.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Longeveron, and consider following LGVN for alerts when major investors trade the stock.